Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00185965 · ClinicalTrials.gov registry record · Phase 1

CPG 7909 + Local Radiotherapy in Recurrent Low-Grade Lymphomas

A Phase 1 study, sponsored by Ronald Levy.

Completed
Registry status
Phase 1
Development phase
30
Enrollment target

NCT00185965 is a Phase 1 study that has completed, run by Ronald Levy. The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00185965, a Phase 1 study, has completed, sponsored by Ronald Levy.

COMPLETED
Registry status
Phase 1
Development phase
30 participants
Enrollment target

Study Summary

Brief summary TBD

Interventions

  • DRUG CPG 7909

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2004-07
Est. Completion 2010-03
Phase Phase 1

Sponsor

Ronald Levy

5 total trials

What the Registry Record Tells You About NCT00185965

The ClinicalTrials.gov registry entry for NCT00185965 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ronald Levy, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which CPG 7909 is the first listed.

NCT00185965 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00185965 about?

NCT00185965 is a clinical study titled "CPG 7909 + Local Radiotherapy in Recurrent Low-Grade Lymphomas". Brief summary TBD

What is the current status of trial NCT00185965?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2004-07. Estimated completion is 2010-03.

What interventions are being tested in trial NCT00185965?

The interventions under investigation include: CPG 7909 (DRUG).

Who is sponsoring clinical trial NCT00185965?

This trial is sponsored by Ronald Levy, which has 5 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.